home / stock / armp / armp short
Short Information | Armata Pharmaceuticals Inc. (NYSE:ARMP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,449 |
Total Actual Volume | 316,198 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 172 |
Average Short Percentage | 0.71% |
Is there a ARMP Short Squeeze or Breakout about to happen?
See the ARMP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-22-2024 | $2.705 | $2.51 | $2.85 | $2.51 | 5,098 | 82 | 1.61% |
04-18-2024 | $2.6 | $2.55 | $2.8 | $2.5 | 31,040 | 1,258 | 4.05% |
04-17-2024 | $3.3 | $2.5 | $3.3 | $2.5 | 34,486 | 2 | 0.01% |
04-11-2024 | $3.43 | $3.31 | $3.46 | $3.31 | 6,525 | 3 | 0.05% |
04-10-2024 | $3.54 | $3.4 | $3.85 | $3.4 | 12,692 | 23 | 0.18% |
04-09-2024 | $3.61 | $3.61 | $3.61 | $3.49 | 3,215 | 4 | 0.12% |
04-08-2024 | $3.82 | $3.61 | $3.82 | $3.61 | 4,720 | 9 | 0.19% |
04-05-2024 | $3.65 | $3.78 | $3.8239 | $3.65 | 4,469 | 1 | 0.02% |
04-02-2024 | $4.11 | $3.66 | $4.11 | $3.61 | 25,758 | 30 | 0.12% |
03-26-2024 | $3.99 | $4.04 | $4.23 | $3.9256 | 14,039 | 6 | 0.04% |
03-25-2024 | $3.6468 | $3.91 | $4.25 | $3.6468 | 57,335 | 111 | 0.19% |
03-22-2024 | $3.72 | $3.74 | $3.78 | $3.48 | 6,274 | 30 | 0.48% |
03-21-2024 | $3.78 | $3.69 | $3.9013 | $3.58 | 13,042 | 7 | 0.05% |
03-19-2024 | $3.664 | $3.78 | $3.9 | $3.59 | 23,168 | 4 | 0.02% |
03-18-2024 | $3.4 | $3.44 | $3.78 | $3.4 | 16,512 | 9 | 0.05% |
03-15-2024 | $3.29 | $3.6 | $3.6 | $3.29 | 8,162 | 7 | 0.09% |
03-13-2024 | $3.8 | $3.45 | $3.83 | $3.45 | 7,918 | 16 | 0.2% |
03-12-2024 | $3.38 | $3.65 | $3.885 | $3.38 | 27,941 | 1,844 | 6.6% |
03-11-2024 | $3.45 | $3.38 | $3.5 | $3.31 | 5,902 | 1 | 0.02% |
03-08-2024 | $3.6 | $3.55 | $3.7 | $3.4518 | 7,902 | 2 | 0.03% |
News, Short Squeeze, Breakout and More Instantly...
Armata Pharmaceuticals Inc. Company Name:
ARMP Stock Symbol:
NYSE Market:
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva PR Newswire Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES , March 4, 20...
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit PR Newswire LOS ANGELES , Feb. 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on...